We are live on
!
Find out more
Winslow Capital Management Portfolio holdings
AUM
$25.6B
1-Year Est. Return
33.75%
This Fund
S&P 500
This Quarter
Est. Return
-2.94%
1 Year Est. Return
+33.75%
3 Year Est. Return
+154.66%
5 Year Est. Return
+213.06%
10 Year Est. Return
+1,176.99%
AUM
$27.4B
AUM Growth
-$2.65B
(-8.8%)
Cap. Flow
-$1.41B
Cap. Flow
% of AUM
-5.15%
Top 10 Holdings %
Top 10 Hldgs %
34.54%
Holding
80
New
9
Increased
26
Reduced
31
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$586M |
| 2 |
AGN
Allergan plc
AGN
|
+$448M |
| 3 |
Intuit
INTU
|
+$415M |
| 4 |
PayPal
PYPL
|
+$410M |
| 5 |
Edwards Lifesciences
EW
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$520M |
| 2 |
eBay
EBAY
|
+$486M |
| 3 |
Baidu
BIDU
|
+$464M |
| 4 |
Cognizant
CTSH
|
+$370M |
| 5 |
ARMH
ARM HOLDINGS PLC ADS
ARMH
|
+$337M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.6% |
| 2 | Consumer Discretionary | 22.45% |
| 3 | Technology | 14.56% |
| 4 | Communication Services | 13.72% |
| 5 | Financials | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Salesforce
CRM
$152B
| $407M | 1.48% |
5,862,801
+909,808
| +18% | +$64.5M |
|
|
AGN
27
DELISTED
Allergan plc
AGN
| $396M | 1.44% |
+1,457,807
| New | +$448M |
|
28
Chipotle Mexican Grill
CMG
$47.5B
| $392M | 1.43% |
27,180,600
+2,426,050
| +10% | +$34.5M |
|
29
Hilton Worldwide
HLT
$70.7B
| $391M | 1.43% |
5,685,387
-203,097
| -3% | -$15.7M |
|
30
Union Pacific
UNP
$173B
| $390M | 1.42% |
4,406,476
-1,488,169
| -25% | -$136M |
|
31
Broadcom
AVGO
$1.87T
| $380M | 1.38% |
30,399,020
+17,756,190
| +140% | +$224M |
|
|
32
Intuit
INTU
$87.1B
| $380M | 1.38% |
+4,278,034
| New | +$415M |
|
33
Ecolab
ECL
$78.6B
| $374M | 1.36% |
3,411,537
+160,166
| +5% | +$17.9M |
|
34
Costco
COST
$423B
| $357M | 1.3% |
2,472,801
+153,450
| +7% | +$21.9M |
|
|
35
PayPal
PYPL
$49.5B
| $355M | 1.29% |
+11,437,570
| New | +$410M |
|
|
MBLY
36
DELISTED
Mobileye N.V.
MBLY
| $332M | 1.21% |
7,310,753
+304,012
| +4% | +$16.7M |
|
37
Medtronic
MDT
$111B
| $330M | 1.2% |
4,936,848
+248,076
| +5% | +$18.3M |
|
38
Ulta Beauty
ULTA
$23B
| $327M | 1.19% |
1,999,470
-49,398
| -2% | -$8.13M |
|
39
Boston Scientific
BSX
$72B
| $322M | 1.17% |
19,615,564
+2,152,198
| +12% | +$36.8M |
|
|
EVHC
40
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $317M | 1.15% |
2,877,418
-232,952
| -7% | -$28.8M |
|
41
PPG Industries
PPG
$25.3B
| $317M | 1.15% |
3,613,296
+433,998
| +14% | +$44.2M |
|
42
Vertex Pharmaceuticals
VRTX
$119B
| $304M | 1.11% |
2,921,786
-105,356
| -3% | -$13.5M |
|
43
Sherwin-Williams
SHW
$86B
| $296M | 1.08% |
3,987,027
+716,940
| +22% | +$62.9M |
|
|
44
Edwards Lifesciences
EW
$51.1B
| $293M | 1.07% |
+12,371,592
| New | +$299M |
|
45
Honeywell
HON
$78.2B
| $268M | 0.98% |
3,146,822
-114,542
| -4% | -$10.4M |
|
46
Trip.com Group
TCOM
$29.8B
| $267M | 0.97% |
8,461,958
-906,188
| -10% | -$31.5M |
|
47
Gilead Sciences
GILD
$163B
| $266M | 0.97% |
2,706,912
-2,609,594
| -49% | -$290M |
|
48
Dollar General
DG
$28.2B
| $265M | 0.96% |
3,652,230
-532,564
| -13% | -$40.7M |
|
49
Liberty Global Class C
LBTYK
$3.63B
| $260M | 0.95% |
7,288,787
+58,955
| +0.8% | +$2.38M |
|
50
DexCom
DXCM
$32.9B
| $254M | 0.93% |
11,851,816
+1,944,816
| +20% | +$43.4M |
|
Similar funds
UIM
VAI
KK
Winslow Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Winslow Capital Management held 80 positions worth $27.4B, down 8.8% from $30.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Winslow Capital Management withdrew a net $1.41B in Q3 2015, closing 12 positions and reducing 31 holdings. Its most notable exit was Biogen, an estimated $520M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Winslow Capital Management opened a new position in Bristol-Myers Squibb worth $546M.
- Winslow Capital Management's largest Q3 2015 buy was Bristol-Myers Squibb: 9,229,864 shares worth $546M.
- Winslow Capital Management added most to Amazon in Q3 2015, an estimated $230M increase.
- Winslow Capital Management's biggest Q3 2015 reduction was Cognizant, cutting an estimated $370M.
- Winslow Capital Management fully exited Biogen in Q3 2015, selling an estimated $520M.
- Winslow Capital Management's ten largest holdings make up 35% of its $27.4B portfolio in Q3 2015.
- Winslow Capital Management opened 9 new positions and closed 12 in Q3 2015.
- Winslow Capital Management's portfolio value fell 8.8% quarter-over-quarter to $27.4B.
Based on Winslow Capital Management's 13F filing for Q3 2015, filed 10 Nov 2015.